Total Payments
$2,207
2020 Payments
$18.91
Companies
17
Transactions
83
Payment Breakdown by Category
Food & Beverage$2,201 (99.7%)
Education$6.02 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,201 | 82 | 99.7% |
| Education | $6.02 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $450.61 | 13 | $0 (2018) |
| Novo Nordisk Inc | $424.53 | 9 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $268.29 | 14 | $0 (2019) |
| PFIZER INC. | $183.09 | 6 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $179.76 | 5 | $0 (2017) |
| Amgen Inc. | $134.36 | 2 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $112.74 | 6 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $112.04 | 7 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $93.16 | 6 | $0 (2017) |
| ARBOR PHARMACEUTICALS, INC. | $57.84 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $18.91 | 1 | Neurocrine Biosciences, Inc. ($18.91) |
| 2019 | $392.63 | 17 | Amgen Inc. ($134.36) |
| 2018 | $873.49 | 29 | Novo Nordisk Inc ($288.83) |
| 2017 | $921.69 | 36 | Janssen Pharmaceuticals, Inc ($345.15) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/01/2020 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: NEUROLOGY | ||||||
| 10/09/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/16/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/08/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/26/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/24/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), APRISO, XIFAXAN | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/19/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/14/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Neuroscience | ||||||
| 05/06/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $120.86 | General |
| Category: Cardiology | ||||||
| 05/03/2019 | ARBOR PHARMACEUTICALS, INC. | Edarbi (Drug) | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/05/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Immunology | ||||||
| 03/30/2019 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/19/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/11/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Lower GI | ||||||
| 02/21/2019 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Immunology | ||||||
| 02/15/2019 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Endocrinology | ||||||
| 02/06/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), APRISO, XIFAXAN | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/01/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/12/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/10/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Diabetes | ||||||
| 11/16/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $43.10 | General |
| Category: Lower GI | ||||||
| 11/15/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $120.47 | General |
| Category: Diabetes | ||||||
| 11/14/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/29/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/17/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
About Dr. James Davis, M.D
Dr. James Davis, M.D is a Infectious Disease healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1376679456.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Davis, M.D has received a total of $2,207 in payments from pharmaceutical and medical device companies, with $18.91 received in 2020. These payments were reported across 83 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,201).
Ad
Practice Information
- Specialty Infectious Disease
- Location Washington, DC
- Active Since 02/26/2007
- Last Updated 07/08/2007
- Taxonomy Code 207RI0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1376679456
Products in Payments
- INVOKANA (Drug) $339.13
- FARXIGA (Drug) $268.29
- Tresiba (Drug) $221.64
- TOUJEO (Drug) $158.54
- Ozempic (Drug) $142.47
- ELIQUIS (Drug) $125.50
- Repatha (Biological) $120.86
- Amitiza (Drug) $112.74
- XARELTO (Drug) $105.46
- XIFAXAN (Drug) $92.96
- JANUVIA (Drug) $75.09
- Victoza (Drug) $48.27
- JARDIANCE (Drug) $37.30
- Cimzia (Drug) $37.25
- Edarbyclor (Drug) $30.01
- VIAGRA (Drug) $27.17
- LANTUS (Drug) $21.22
- CHANTIX (Drug) $19.92
- RELISTOR (Drug) $19.08
- INGREZZA (Drug) $18.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Washington
Dr. Robert Gasser, Md, MD
Infectious Disease — Payments: $922,181
Infectious Disease $922,181
Princy Kumar
Infectious Disease — Payments: $417,633
Infectious Disease $417,633
Dr. Jose Chavez, Md, MD
Infectious Disease — Payments: $293,279
Infectious Disease $293,279
Dr. Gebeyehu Teferi, M.d, M.D
Infectious Disease — Payments: $97,206
Infectious Disease $97,206
Dawn Fishbein, Md, MD
Infectious Disease — Payments: $24,671
Infectious Disease $24,671
Dr. Glenn Wortmann, M.d, M.D
Infectious Disease — Payments: $14,236
Infectious Disease $14,236